Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Filter by Custom Post Type

MYDX

MyDx, Inc.

Bullish (9) 75%
Bearish (3) 25%

Vote by Logging in -or- Becoming a Registered Member

Home Forums MYDX

Price
0.0049
Change
-0.0003 -5.7692%
Ask
N/A
Bid
N/A
Previous Close
0.0052
Open
0.0048
Volume
11,084,574
Average Vol (30d)
18,005,300
Daily Range
0.0046 - 0.0052
52Wk Range
0.0010 - 0.1840
Dividend
N/A
Net Dividend Yield
N/A

MYDX Latest Activity

Latest News for: MyDx, Inc.

MyDx Files Complaint Against Former Chief Operating Officer, Protects Unique AeroDx Diagnostic Platform and Addresses Toxic Financier's Unauthorized Conversion

Published: Tuesday July 18, 2017

SAN DIEGO, July 18, 2017 /PRNewswire/ -- MyDx, Inc. (MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer initially designed for cannabis professionals and retail consumers to measure the chemicals in cannabis and track their feedback on how each sample is impacting their physiology, today announced that all previously reported variable toxic debts have been satisfied through the unauthorized conversion of the Crown Bridge note and has also filed a lawsuit against its former COO and other defendants who have attempted to create a competitive advantage with its anticipated product launch of its air quality sensor: AeroDx®. On July 14, 2017, the Company and its Chief Executive Officer, Daniel Yazbeck, filed a complaint in Superior Court of California against a series of Defendants who have allegedly engaged in unfair business practices, made false statements about the Company, its products, and Mr. Yazbeck at investor events and on online investor platforms.  There can be no assurance about the results or on the outcome of the lawsuit, however, the company took aggressive steps it felt were necessary to protect its business and its shareholders.

MyDx Supports Product Sales and Toronto's Gay Pride Parade Through Canadian Radio, Taxi Cab Advertisements and Billboards

Published: Thursday June 29, 2017

Company Receives Initial Product Sales from its Canadian Campaign as it Ramps Up Over the Coming Month SAN DIEGO , June 29, 2017 /PRNewswire/ --  MyDx, Inc. (OTCQB:MYDX), a science and technology company ...

MyDx Enters Into An ~$80,000 MyDx360 SaaS Licensing And Services Agreement With Retailer BlackSwan

Published: Monday June 19, 2017

SAN DIEGO, June 19, 2017 /PRNewswire/ -- MyDx, Inc. (MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailments they report it alleviates, today announced a definitive agreement with BlackSwan, a developer and retailer of custom vaporizers, to provide a community engagement software platform to support its new product development initiatives under the terms of MyDx360. As part of the MyDx360 agreement, BlackSwan chose from one of MyDx's base chemical formulations that best alleviated pain and inflammation according to the MyDx community. From there, MyDx software enabled BlackSwan to "boost" that formula by changing various cannabinoid and terpene parameters as well as other natural organic terpenes to come to a final formula uniquely formulated by BlackSwan.

MYDX Chat

Only logged in users are allowed to enter the chat

Join Chat by Logging in -or- Becoming a Registered Member

This forum contains 7 topics and 1 reply, and was last updated by Profile gravatar of Douglas Douglas 3 months, 1 week ago.

Viewing 7 topics - 1 through 7 (of 7 total)
Viewing 7 topics - 1 through 7 (of 7 total)

You must be logged in to create new topics.

Register Now